At Staar, Farrell said he would look for opportunities for "improvement, optimization and efficiency," saying the company is positioned to deliver strong returns as the refractive surgery market stabilizes. "We have a best-in-class product, a strong network of surgeons, and a clear path to continued market share gains in a market that we expect to grow substantially over time," the new CEO said.